OEM News

Patent for Fluids Testing in Industrial Applications via Mobile Devices and Apps

Broadens company’s platform technology applications beyond mHealth and into health and non-health related industrial markets.

LabStyle Innovations Corp., developer of the Dario Blood Glucose Monitoring System, announced today the U.S. Patent and Trademark Office has issued the Company patent #9257038 titled, “Fluids testing apparatus and methods of use.”
 
The invention addresses mobile, hand held, miniature laboratory systems and testing of fluids including bodily fluids such as blood, urine, saliva, and amniotic fluid, as well as non-bodily fluids for industrial, defense and security applications including environmental and food safety.
 
“We are very pleased to be granted our third patent in the U.S. for our platform fluids testing technology on a mobile device. This patent fortifies our IP rights around the Dario Blood Glucose Monitoring system which just launched in the U.S. for the diabetes market,” said Erez Raphael, Chairman and CEO of LabStyle Innovations.
 
“Furthermore, this patent vastly expands the value of our inventions, by extending its applications beyond chronic diseases, into industrial fluids testing which itself is a multi-billion market,” Raphael added.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics